Kosmos Energy Boosts Financial Flexibility with Extended and Expanded $1.35B Loan Facility

Kosmos Energy (NYSE/LSE: KOS) ("Kosmos" or the "Company") announced today that it has successfully re-financed its reserve-based lending ("RBL") facility extending the maturity by

Kosmos Energy (NYSE/LSE: KOS) (“Kosmos” or the “Company”) announced today that it has successfully re-financed its reserve-based lending (“RBL”) facility extending the maturity by approximately three years, with the RBL facility’s final maturity now in December 2029.

In conjunction with the spring re-determination, the total RBL facility size has been increased to $1.35 billion (from $1.25 billion) with current commitments of approximately $1.2 billion. Discussions with additional potential lenders are ongoing and are expected to increase commitments later this year towards the RBL facility size. $800 million is currently drawn against the RBL facility with the first amortization payment scheduled for April 1, 2027.

The RBL facility is secured against the Company’s production assets in Ghana and Equatorial Guinea with the Company’s assets in the US Gulf of Mexico and Mauritania & Senegal remaining unencumbered. The resulting borrowing base following the spring re-determination significantly exceeds the RBL facility size. The interest margin payable on the RBL increased slightly compared to the previous facility, reflecting the current banking market environment, with the new interest margin on the RBL facility commencing at 400 basis points above the Secured Overnight Financing Rate (“SOFR”) for the first two years.

As part of the RBL facility re-financing, the Company has downsized its revolving credit facility (“RCF”) from $250 million to approximately $165 million with some banks transferring their commitments from the RCF to the RBL in anticipation of the RCF maturing at the end of 2024.

Total
0
Shares
Related Posts
Read More

Roku Stock Down 22% Despite ‘Almost Perfect Quarter’: Analyst Expects Stock To Be ‘Range-Bound Until Platform Growth Returns’

Roku stock slid on lower early trading on Feb. 16 due to a cautionary statement on 2024 spending deceleration in the entertainment industry. Despite a Q4 earnings beat, analysts have mixed opinions on the company's future growth.

AMZN

Read More

Protagenic Therapeutics’ Peptide PT00114 To Be Highlighted At Boston Summit In Presentation Titled “Novel Blood-Brain Barrier Penetrating Peptide: Opening New Doors in Neuro-Psychiatric Treatment” On April 23, 2024

Chief Operating Officer to Present Key Advances at Peptide Therapeutics SummitNEW YORK, NY / ACCESSWIRE / April 17, 2024 / Protagenic Therapeutics, Inc. (NASDAQ:PTIX), a pioneer in biopharmaceutical research, announced

PTIX